A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Public ClinicalTrials.gov record NCT00196365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval Compared to Conventional Oral Contraceptive Therapy for Cyclic Pelvic Pain
Study identification
- NCT ID
- NCT00196365
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Duramed Research
- Industry
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Interventions
- levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets Drug
- levonorgestrel/EE 0.15/0.03 mg tablets and placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2004
- Primary completion
- Jun 30, 2007
- Completion
- Jun 30, 2007
- Last update posted
- May 11, 2014
2005 – 2007
United States locations
- U.S. sites
- 18
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duramed Investigational Site | Huntsville | Alabama | 35801 | — |
| Duramed Investigational Site | Phoenix | Arizona | 85032 | — |
| Duramed Investigational Site | San Diego | California | 92108 | — |
| Duramed Investigational Site | Denver | Colorado | 80202 | — |
| Duramed Investigational Site | Tampa | Florida | 33607 | — |
| Duramed Investigational Site | Decatur | Georgia | 30034 | — |
| Duramed Investigational Site | Moorestown | New Jersey | 08057 | — |
| Duramed Investigational Site | Charlotte | North Carolina | 28222 | — |
| Duramed Investigational Site | Columbus | Ohio | 43205 | — |
| Duramed Investigational Site | Columbus | Ohio | 43213 | — |
| Duramed Investigational Site | Medford | Oregon | 97504 | — |
| Duramed Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Duramed Investigational Site | Memphis | Tennessee | 38120 | — |
| Duramed Investigational Site | Salt Lake City | Utah | 84124 | — |
| Duramed Investigational Site | Newport News | Virginia | 23602 | — |
| Duramed Investigational Site | Norfolk | Virginia | 23507 | — |
| Duramed Investigational Site | Spokane | Washington | 99207 | — |
| Duramed Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00196365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00196365 live on ClinicalTrials.gov.